We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9945:TWSERuentex Development Co., Ltd. Analysis

Data as of 2026-03-15 - not real-time

NT$27.90

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Ruentex Development (9945.TW) is trading at TWD 27.9, sitting below its 20‑day (28.75), 50‑day (29.27) and 200‑day (29.91) simple moving averages, indicating a short‑term bearish bias. The MACD histogram remains negative and the RSI at 39 suggests the stock is approaching oversold territory, while volume is on an increasing trend, providing a modest technical cushion near the identified support of 27.1. Fundamentally, the company boasts a striking 60.9 % revenue growth YoY and a PE of 8.1, far below the industry average of 29.1, positioning it as a clear undervaluation relative to peers. The DCF‑derived fair value of 29.87 implies a ~7 % upside from the current price, and a dividend yield of 3.94 % with a 32 % payout ratio underscores cash‑return attractiveness.
However, the firm carries a high debt load (≈ 62 billion TWD) and negative free cash flow, which tempers the upside narrative, especially in a sector sensitive to economic cycles. Volatility over the past 30 days sits near 22 % and beta is modest at 0.63, reflecting moderate market sensitivity but limited systemic risk. Given the blend of strong growth metrics, solid dividend sustainability, and a technical backdrop that may soon reverse, the stock presents a compelling case for investors with a medium‑to‑long horizon.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below all major moving averages
  • Negative MACD and RSI near oversold
  • Increasing volume near support level

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued relative to industry PE
  • Strong revenue growth (60.9%)
  • Attractive dividend yield with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • DCF fair value suggests upside
  • Sustainable dividend and solid cash flow generation
  • Moderate beta and manageable market volatility

Key Metrics & Analysis

Financial Health

Revenue Growth60.90%
Profit Margin27.28%
P/E Ratio8.1
ROE11.92%
ROA2.22%
Debt/Equity56.56
P/B Ratio0.8
Op. Cash FlowNT$5.4B
Free Cash FlowNT$-5321264640
Industry P/E29.1

Technical Analysis

TrendBearish
RSI39.3
SupportNT$27.10
ResistanceNT$29.85
MA 20NT$28.75
MA 50NT$29.27
MA 200NT$29.91
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueNT$29.87
GradeUndervalued
TypeBlend
Dividend Yield3.94%

Risk Assessment

Beta0.63
Volatility22.00%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.